Duration of antiviral therapy for cholestatic HCV recurrence may need to be indefinite
- 作者Deepak V. Gopal; Hugo R. Rosen
- 卷第9卷
- 期第4期
- 印刷ISSN1527-6465
- 电子ISSN1527-6473
- 文件大小465.96KB
- 发表时间2003
- DOI10.1053/jlts.2003.50062
- 页码348-353
Fas-mediated cholangiopathy in the murine model of graft versus host diseaseYoshiyuki Ueno; Motoyasu Ishii; Kaichiro Yahagi; Yutaka Mano; Norihiro Kisara; Norio Nakamura; Tooru Shimosegawa; Takayoshi Toyota; Shigekazu Nagata · 2000
Primary biliary cirrhosis with antibody against carbonic anhydrase II associates with distinct immunological backgroundsYoshiyuki Ueno; Motoyasu Ishii; Takehiko Igarashi; Yutaka Mano; Kaichiro Yahagi; Norihiro Kisara; Yoshie Kobayashi; Hirofumi Niitsuma; Koju Kobayashi; Tooru Shimosegawa · 2001
A Patient with Clinical Features of Acute Hepatitis E Viral Infection and Autoimmune HepatitisNagasaki, Futoshi; Ueno, Yoshiyuki; Mano, Yutaka; Igarashi, Takehiko; Yahagi, Kaichiro; Niitsuma, Hirofumi; Okamoto, Hiroaki; Shimosegawa, Tooru · The Tohoku Journal of Experimental Medicine · 2005